NCT00272766View on ClinicalTrials.gov

Macugen for Histoplasmosis

NATerminatedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

May 31, 2007

Conditions

Ocular HistoplasmosisChoroidal Neovascularization

Interventions

DRUG

pegaptanib sodium

Trial Locations (1)

63110

Barnes Retina Institute, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Barnes Retina Institute

OTHER